Clearside Biomedical to Present at the Stifel 2020 Virtual Healthcare Conference

Rhea-AI Summary

Clearside Biomedical, a biopharmaceutical company focused on vision restoration treatments, will present a company overview at the Stifel 2020 Virtual Healthcare Conference on November 17, 2020, at 8:40 a.m. ET. The presentation will be accessible via a live webcast on the Clearside website, with an archived version available for three months. Clearside specializes in innovative approaches to treat serious back of the eye diseases using their proprietary SCS Microinjector technology, which allows targeted delivery of treatments.

ALPHARETTA, Ga., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that Management will present a company overview at the Stifel 2020 Virtual Healthcare Conference on November 17, 2020 at 8:40 a.m. ET.

A link to the live and archived webcast may be accessed on the Clearside website under the Investors section: Events and Presentations. An archive of the webcast will be available for three months.

About Clearside Biomedical

Clearside Biomedical, Inc. is a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases. Clearside’s proprietary SCS Microinjector^® targets the suprachoroidal space (SCS^®) and offers unique access to the macula, retina and choroid where sight-threatening disease often occurs. The Company’s SCS injection platform is an inherently flexible, in-office, non-surgical procedure, intended to provide targeted delivery to the site of disease and to work with both established and new formulations of medications, as well as future therapeutic innovations such as gene therapy. For more information, please visit www.clearsidebio.com.

Investor and Media Contacts:

Jenny Kobin
Remy Bernarda
ir@clearsidebio.com
(678) 430-8206

Source: Clearside Biomedical, Inc.

FAQ

What is Clearside Biomedical's stock symbol?

Clearside Biomedical's stock symbol is CLSD.

When will Clearside Biomedical present at the Stifel 2020 Virtual Healthcare Conference?

Clearside Biomedical will present on November 17, 2020, at 8:40 a.m. ET.

How can I access the webcast of Clearside Biomedical's presentation?

The webcast can be accessed on Clearside's website under the Investors section.

What is the focus of Clearside Biomedical?

Clearside Biomedical focuses on developing treatments to restore and preserve vision for patients with back of the eye diseases.

What technology does Clearside Biomedical use for treatment delivery?

Clearside Biomedical uses the SCS Microinjector technology for targeted delivery of treatments.